Per the article
In a letter to be published in the New England Journal of Medicine next week, the Mount Sinai team details five case studies of young patients who had strokes at home from March 23 to April 7. They make for difficult reading: The victims’ ages are 33, 37, 39, 44 and 49, and they were all home when they began to experience sudden symptoms, including slurred speech, confusion, drooping on one side of the face and a dead feeling in one arm.
One died, two are still hospitalized, one was released to rehabilitation, and one was released home to the care of his brother. Only one of the five, a 33-year-old woman, is able to speak.
It is a blood disease.
The clotting feature hits A+. Most common.
I wonder how often blood clots occur. Is it very rare or is it common enough to make you wonder if otherwise healthy people should seek treatment at the earliest possible stage of covid? Something to keep in mind if you are considering riding it out. Could you be treated prophylactically with anticoagulants?
From the protocol that was linked here today:
“Full anticoagulation: Unless contraindicated we suggest FULL anticoagulation (on
admission to the ICU) with enoxaparin, i.e 1 mg kg s/c q 12 hourly (dose adjust with
Cr Cl < 30mls/min). Heparin is suggested with CrCl < 15 ml/min. Alternative approach:
Half-dose rTPA: 25mg of tPA over 2 hours followed by a 25mg tPA infusion administered
over the subsequent 22 hours, with a dose not to exceed 0.9 mg/kg followed by full
anticoagulation. On transfer to floor, consider reducing enoxaparin to 40-60 mg /day.
Note: Early termination of ascorbic acid and corticosteroids will likely result in a rebound
effect.”